Нестабильность митохондриальной и ядерной ДНК в клетках периферической крови онкологических больных при проведении радио-химиотерапии Medline.ru - медико-биологический информационный портал Медлайн.ру

1. Donnelly J.G. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response. Ther. Drug Monit., 2004, 26, 231-235

2. Danesi, R. De Braud, F Fogli S., Martino De Pas T., Di Paolo A., Curigliano G. and Del Tacca M. Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer. Pharmacological Reviews. 2003, 55, 57-103.

3. Wardell TM, Ferguson E, Chinnery PF, Borthwick GM, Taylor RW, Jackson G, Craft A, Lightowlers RN, Howell N, Turnbull DM. Changes in the human mitochondrial genome after treatment of malignant disease. Mutat Res., 2003, 525, 19-27.

4. Loeb L.A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 1994, 54: 5059-5063.

5. Sherbet G.W. and Lakshmi M.S. The genetics of cancer. 1997, Academic press, San Diego.

6. T. Grundei, H. Vogelsang, K. Ott, J. Mueller, M. Scholz, K. Becker, U. Fink, J. R. Siewert, H. Höfler and G. Keller. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma. Clinical Cancer Research, 2000, 6, 4782-4788.

7. Prasanna PG, Hamel CJ, Escalada ND, Duffy KL, Blakely WF.Biological dosimetry using human interphase peripheral blood lymphocytes. Mil. Med., 2002, 167(2 Suppl).

8. Carew J.S., Zhou Y., Albitar M., Carew J.D., Keating M.J., Huang P. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia. 2003, 17, 1437-1447.

9. Litt, M. and Luty, J.A. (1989) A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am. J. hum. Genet., 44, 397-401.

10. Tautz, D. (1989) Hypervariability of simple sequence as a general source for polymorphic DNA markers. Nucleic Acid Res., 17, 6463-6471.

11. Weber, J.L. and May, P.E. (1989) Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am. J. hum. Genet., 44, 388-396.

12. Weber, J.L. and Wong, С. (1993) Mutation of human short tandem repeats. Hum.Mol.Genet ., 2, 388-396.

13. Eshleman, J.R. and Markowitz, S.D. (1996) Mismatch repair defects in carcinogenesis. Hum.Mol.Genet ., 5, 1489-1494.

14. Arnheim, N. and Shibata, D. (1997) DNA mismatch repair in mammals: role in disease and meiosis. Curr. Opin. Genet. Dev., 7, 364-370.

15. Lothe, R.A. (1997) Microsatellite instability in human solid tumors. Mol. Med. Today, 2, 61-68.

16. Aaltonen, L.A., Peltomaki, P., Leach, F.S., Sistonene, P., Pylkkanen, L., Mecklin, J.P., Jarvinen, H., Powell, S.M., Jen, J., Hamilton, S.R., Peterson, G.M., Kinzler, K.W., Vogelstein, B., de la Chapelle, A. (1993) Clues to the pathogenesis of famial colorectal cancer. Science, 260, 812-816.

17. Papadopoulus, N., Nicolaides, N.C., Wei, Y.F., Ruben, S.M., Carter, K.C., Rosen, S.A., Haseltine, W.A., Fleischmann, R.D., Fraser, C.M., Adams, M.D., Venter, J.C., Hamilton, S.R., Petersen, G.M., Watson, P., Lynch, H.T., Peltomaki, P., Mecklin, J.P., de la Chapelle, A., Kinzler, K.W., Vogelstein, B. (1994) Mutation of a mutL homolog in hereditary colon canser. Science, 263, 1625-1629.

18. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G.M., Lynch, H., Feunteun, J., Odevilee, P., Cornelisse, C.J., Menko, F.H., Daly, P.A., Ormiston, W., McManus, R., Pye, C., Lewis, C.M., Cannon-Albright, L.A., Petro, J., Ponder, B.A.J., Skolnik, M.H., Easton, D.F., Goldgar, D.E., Stratton, M.R. (1994) Localization of a breast canser susceptibility gene, TRCA2б to chromosome 13q12-13. Science, 265, 2088-2090.

19. Yee, C.J., Roodi, N., Verrier, C.S., Parl, F.F. (1994) Microsatellite instability and loss of heterozygosity in breast canser. CanserRes., 54, 1641-1644.

20. Knudson, A.G., (1993) Antioncogenes and human cancer. Proc. Nat. Acad. Sci. USA, 90, 10914-10920.

21. Jass, J.R., Cottier, D.S., Jeevaratnam, P., Pokos, V., Holdaway, K.M., Bowden, M.L., Van de Water, N.S., Browett P.J., (1995) Diagnostic use of microsatellite instability in hereditary non polyposis colorectal cancer. Lancet., 346, 1200-1201.

22. Aaltonen, L.A., Aslovaara, M.D., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R.B., Kaariainen, H., Eskelinen, M.D., Jarvinen, H., Mecklin, J.P., Chapelle, A. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med., 338, 1481-1487.

23. Beckman, K.B., Ames, B.N., (1999) Endogenous damage of mtDNA. Mutat. Res., 424, 51-58.

24. Sawyer, D.E., Van Houten, B. (1999) Repair of DNA damage in mitochondria. Mutat. Res., 434, 161-176.

25. Marcelino, L.A., Thilly, W.G. (1999) Mitochondrial mutagenesis in human cells and tissues. Mutat. Res., 434, 177-203.

26. May, A., Bohr, V.A. (2000) Gene-specific repair of a gamma-ray-induced DNA strand breaks in colon cancer cells: no coupling to transcription and no removal from the mitochondrial genome. Biochem. Biophys. Res. Commun., 269, 433-437.

27. LeDoux, S.P., Wilson, G.L. (2001) Base excision repair of mitochondrial DNA damage in mammalian cells. Prog. Nucleic. Acid. Res. Mol. Biol., 68, 273-284.

28. Dianov, G.L., Souza-Pinto, N., Nyaga, S.G., Thybo, T., Stevnsner, T., Bohr, V.A. (2001) Base excision repair in nuclear and mitochondrial DNA. . Prog. Nucleic. Acid. Res. Mol. Biol., 68, 285-297.

29. Gaziev, A.I., Podlutskii, A.J. (2003) Low efficiency of DNA repair system in mitochondria. Tsitologija, 45(4), 403-417.

30. Khrapko, K., Coller, H., Andre, P., Li, X.-C., Hanekamp, J.S., Thilly, W.G. (1997) Mitochondrial mutation spectra in human cells and tissues. Proc. Natl. Acad. Sci. USA, 94, 13798-13803.

31. Ozawa, T. (1997) Genetic and functional changes in mitochondria associated with aging. Physiol.Rev, 77, 425-464.

32. Wallace, D.C. (1999) Mitochondrial disease in mouse and man. Science., 283, 1482- 1488.

33. Kubota, N., Hayashi, J.-I., Inada, T., Iwamura, Y. (1997) Induction of particular deletion in mtDNA by X rays depends on the inherent radiosensivity of the cells. Radiation Res., 148, 395-398.

34. Prithivirajsingh, S., Story, M.D., Bergh, S.A., Geara, F.B., Ang, K.K., Ismail, S.M., Stevens, C.W., Buchholz, T.A., Brock W.A. (2004) Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation. FEBS Lett., 571 (1-3), 227- 232.

35. Patrushev, M.V., Patrusheva, V.E., Kasymov V.A., Evdokimovsky E.V., Ushakova T.E., and Gaziev A.I. (2005) The mtDNA Release and Activation of its Replication in Tissues of Irradiated Mice. Tsitologiya, in press.

36. Patrushev, M., Kasumov, V., Patrusheva, V., Ushakova, E., Gogvadze, V., and Gaziev, A. (2004) Mitochondrial permeability transition triggers the release of mtDNA fragments. Cell. Mol. Life Sci., 61, 24, 3100-3103.

37. www.c stl.nist.gov/biotech/strbase

38. Anand, S., Verma, H., Kumar, L., Singh, N., (1995) Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamicin. Cancer Lett. 88, 101-105

39. Ciocca, D.R., Rozados, V.R., Cuello Carrion, F.D., Gervasoni, S.I., Matar, P., Scharovsky, O.G., (2003) Hsp25 and Hsp70 in rodent tumors treatment with doxorubicin and lovastatin. Cell Stress Chaperones. 8, 26-36.

40. Skladanowski, A. and Konopa, J. (1994) Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity. (1994) Biochem. Pharmacol. 47, 2279-2287.

41. Larson, E.D., Drummond, J.T., (2001) Human mismatch repair and G.T mismatch binding by hMutSα in vitro is inhibited by adriamycin, actinomycin D and nogalamycin. J. Biol. Chem. 276, 9775-9783.

42. Shapiro B., Chakrabarty M., Cohn E. M., Leon S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.

43. Leon S. A., Shapiro B., Sklaroff D. M., Yaros M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.

44. Stroun M., Anker P., Lyautey J., Lederrey C., Maurice P. A. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 28: 707-712, 1987.

45. Maebo A. Plasma DNA level as a tumour marker in primary lung cancer. Jpn. J. Thorac. Dis., 28: 1085-1091, 1990.

46. Shapiro B., Chakrabarty M., Cohn E. M., Leon S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.

47. Bacon AL, Farrington SM, Dunlop MG. Mutation frequency in coding and non-coding repeat sequences in mismatch repair deficient cells derived from normal human tissue. Oncogene. 2001, 20, 7464-7471.

48. S. Lee, D. Chang, A. Goel, C. R. Boland, W. Bugbee, D. L. Boyle and G. S. Firestein Microsatellite Instability and Suppressed DNA Repair Enzyme Expression in Rheumatoid Arthritis The Journal of Immunology, 2003, 170: 2214-2220

49. M. Ricchetti., F. Tekaia, B. Dujon Continued colonization of the Human genome by mitochondrial DNA. PLOS Biology, 2004, 2, 1313-1325.

50. Patrushev M, Kasymov V, Patrusheva V, Ushakova T, Gogvadze V, Gaziev AI. Release of mitochondrial DNA fragments from brain mitochondria of irradiated mice. // Mitochondrion. 2006 V.6 P. 43-47